Table of Contents
Our population is aging. The United Nations reports that by 2050, the number of people over the age of 85 on our planet is set to triple. But a longer life span isn’t the same as a longer healthspan, and new research on acid ceramidase senescence ferroptosis interactions from the Salk Institute is exploring the cellular mechanisms driving age-related dysfunction.
Two Cellular Processes Behind Acid Ceramidase Senescence Ferroptosis Research
The latest efforts to understand cellular aging look at two processes prevalent in aged cells: senescence, in which cells stop dividing but don’t die, and ferroptosis, in which cells lose their ability to regulate fats and eventually die. While studying human lung cells, the Salk team discovered that elevated levels of the enzyme acid ceramidase make senescent cells more susceptible to ferroptosis and can pass that vulnerability to neighboring cells.
A Pathway Already Being Targeted for Other Diseases
Experimental drugs that target acid ceramidase have already been developed for other therapeutic purposes, demonstrating that acid ceramidase is targetable and lighting the way to future innovation that could extend healthspans. The study published in Cell Death and Disease on July 10, 2026.
Why This Acid Ceramidase Senescence Ferroptosis Discovery Matters
“Senescent cells are linked to many age-related conditions, including arthritis, poor wound healing, and neurodegenerative diseases like Alzheimer’s or Parkinson’s,” said senior and co-corresponding author Pam Maher, PhD, a research professor at Salk. “Our findings are a big milestone in the ongoing public health effort to support healthy aging, as we now have a novel target for developing new therapeutics that could be applied to a multitude of diseases and disorders.”
What Ferroptosis and Senescence Actually Are
Maher is the person to ask about ferroptosis, since she discovered the cellular pathway and named it (originally “oxytosis”) in 2001. Ferroptosis is an iron-dependent cell death pathway in which the accumulation of lipid peroxides becomes toxic to cells. Healthy cells keep lipid peroxides at steady levels with the help of glutathione, an antioxidant that can stave off ferroptosis.
Building on Prior Research Linking Ferroptosis to Neurodegeneration
Recent studies have reinforced links between ferroptosis and Alzheimer’s and Parkinson’s diseases, including another recent study from Maher’s lab. In their recent Cell Death Discovery paper, Maher’s lab discovered that chronic iron overexposure in neurons makes them less resilient over time and more vulnerable to neurodegeneration.
What Senescent “Zombie” Cells Do
Cellular senescence is a biological process in which cells don’t completely die but also aren’t quite alive. Often referred to as “zombie” cells, senescent cells are a hallmark of aging. Though sometimes they are harmless, other times they release harmful factors into surrounding tissues and can promote the development of diseases or disorders, including cancer.
How Researchers Connected Acid Ceramidase Senescence Ferroptosis Sensitivity
Since ferroptosis and senescence have been independently linked to age-related dysfunction, and both have become promising therapeutic targets, the Salk team wondered whether there was any overlap in the two cellular processes. To find an answer, researchers cultured senescent human lung cells in the lab, then induced ferroptosis in the senescent cells to find they were far more sensitive to the cell death pathway than young, healthy cells.
Identifying the Enzyme Responsible
The sensitivity began as senescent cells expressed progressively higher levels of acid ceramidase. After discovering that excessive acid ceramidase drives cell sensitivity to ferroptosis, the researchers removed the enzyme from senescent and non-senescent cells to see whether its absence would make cells more resilient to induced ferroptosis. Removal of acid ceramidase from cells protected both young and old cells from ferroptosis.
A Novel Pathway Behind Acid Ceramidase Senescence Ferroptosis Connections
“This is an entirely novel pathway that is independent of the mechanisms usually associated with ferroptosis-induced cell death, as it doesn’t involve any changes in iron or glutathione levels but instead modulates the lipid metabolism,” said first author David Soriano-Castell, PhD, a postdoctoral researcher in Maher’s lab.
A Vulnerability That Spreads to Neighboring Cells
The Salk team also observed something else: vulnerable senescent cells were able to pass their vulnerability on to neighboring cells. This helps explain why only a few senescent cells can turn into more, ultimately impacting a larger tissue as time goes on. “We have unraveled a new mechanistic connection between ferroptosis and senescence,” Soriano-Castell explained. “This gives us a clear target that would eliminate two birds with one stone, eliminating senescent cells and keeping neighboring cells healthy for longer.”
How Acid Ceramidase Senescence Ferroptosis Research Could Advance Healthy Aging
Unrelated to the Salk study, scientists have already developed drugs to target acid ceramidase for the treatment of other diseases in which this enzyme also plays a role. The Salk findings bring forward a new potential use case for these drugs, and the fact that they are already in development is a great proof-of-concept that drugs can, in fact, be designed to target the enzyme.
What Comes Next in This Research
“This is only the beginning,” Soriano-Castell said. “The next step is finding a more complete pathway and translating into animals and tissues, then clinical trials of our own, and so on. But what is important is that acid ceramidase is targetable, and other labs have already gotten that work started, later on, we can hopefully build on what they learn.”
What This Means for the Future of Healthy Aging Research
“The more we learn about ferroptosis, the more possibilities there are for healthy aging innovations,” Maher added. “This is an exciting time to be studying aging, resilience, and longevity, and I look forward to continuing to see how ferroptosis can be a useful target.” As Salk researchers move toward animal and eventual clinical testing, this discovery linking acid ceramidase senescence ferroptosis vulnerability offers a concrete, already-druggable target that could inform therapies spanning arthritis, neurodegenerative diseases, cancer, and other conditions tied to senescent cell accumulation.
For more healthcare industry updates, insights and news, visit DistilINFO. Click here to subscribe to stay informed.
